MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Ethosuximide

Ethosuximide 250mg capsules

Use with caution

Stability notes for Ethosuximide 250mg capsules

Store in airtight containers.

Provenance

This compatibility recommendation is derived from generic ethosuximide 250mg capsules.

Suppliers (13) of Ethosuximide 250mg capsules
Emeside 250mg capsules (Fontus Health Ltd)
Epesri 250mg capsules (Strides Pharma UK Ltd)
Ethosuximide 250mg capsules (A A H Pharmaceuticals Ltd)
Ethosuximide 250mg capsules (Accord-UK Ltd)
Ethosuximide 250mg capsules (Alliance Healthcare (Distribution) Ltd)
Ethosuximide 250mg capsules (Aristo Pharma Ltd)
Ethosuximide 250mg capsules (CST Pharma Ltd)
Ethosuximide 250mg capsules (Essential Generics Ltd)
Ethosuximide 250mg capsules (Medihealth (Northern) Ltd)
Ethosuximide 250mg capsules (Necessity Supplies Ltd)
Ethosuximide 250mg capsules (Neuraxpharm UK Ltd)
Ethosuximide 250mg capsules (Noumed Life Sciences Ltd)
Ethosuximide 250mg capsules (Strides Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.